MedTrace Logo

Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma

NCT06302881 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2024-03-12

No results posted yet for this study

Summary

This study introduces a novel transfer learning-based contrastive language-image pretraining adapter (CLIP-adapter) model for predicting the tumor-stroma ratio (TSR) in pancreatic ductal adenocarcinoma (PDAC) using preoperative dual-phase CT images. The primary aim is to develop an efficient and accessible tool for risk stratification and personalized treatment planning.

Conditions

Sponsors & Collaborators

  • First Affiliated Hospital of Chongqing Medical University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2022-07-31
Completion
2024-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06302881 on ClinicalTrials.gov